Is ASP2215 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use ASP2215? Is ASP2215 safe for nursing mother and child? Does ASP2215 extracts into breast milk? Does ASP2215 has any long term or short term side effects on infants? Can ASP2215 influence milk supply or can ASP2215 decrease milk supply in lactating mothers?
Answer by DrLact: About ASP2215 usage in lactation
No information is available on ASP2215 during breastfeeding. It is 94% bound to plasma proteins, so amounts in milk are likely to be low; however, it has a long half-life of about 113 hours. The manufacturer recommends that breastfeeding be discontinued during ASP2215 therapy and for 2 months after the last dose.
Alternate Drugs
Cetuximab(Unsafe)
Etoposide(Dangerous)
Bleomycin(Dangerous)
Carboplatin(Dangerous)
Doxorubicin(Dangerous)
Vinorelbine(Dangerous)
Imatinib(Unsafe)
Paclitaxel(Dangerous)
Cyclophosphamide(Dangerous)
Dacarbazine(Dangerous)
Fluorouracil(Dangerous)
Cisplatin(Unsafe)
Azelaic Acid(Safe)
Dasatinib(Unsafe)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Busulfan(Dangerous)
Docetaxel(Dangerous)
Rituximab(Low Risk)
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Gemcitabine(Dangerous)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Vincristine(Dangerous)
Letrozole(Dangerous)
Tamoxifen(Dangerous)
Erlotinib(Unsafe)
Trastuzumab(Unsafe)
Exemestane(Dangerous)
Mitoxantrone(Dangerous)
Cladribine(Dangerous)
Mercaptopurine(Safe)
Nivolumab(Unsafe)
Ipilimumab(Unsafe)
Hydroxyurea(Low Risk)
Vinblastine(Dangerous)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Gemcitabine(Dangerous)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Allopurinol(Safe)
Erlotinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)